Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer

Completed · Phase 4

Conditions studied: Breast Cancer

In brief

To compare the kinetics and efficacy of two functionally different diagnostic agents, Lymphoseek (CD206 receptor targeted) and 99mTc-Sulfur Colloid (SC) (Sulfur Colloid non-specific mapping agent) in intraoperative lymphatic mapping (ILM) and Sentinel Lymph Node Biopsy (SLNB).

Key facts

Study ID
NCT02287675
Run by
Kettering Health Network
People needed
40
Starts
2015-01-19
Expected to finish
2017-08-31
Last updated by the study team
2020-07-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.